PMID- 15023530 OWN - NLM STAT- MEDLINE DCOM- 20040505 LR - 20171116 IS - 0014-4827 (Print) IS - 0014-4827 (Linking) VI - 294 IP - 2 DP - 2004 Apr 1 TI - Immortalization in a normal foreskin fibroblast culture following transduction of cyclin A2 or cdk1 genes in retroviral vectors. PG - 406-19 AB - Human diploid fibroblasts (HDF) rarely, if ever, undergo spontaneous transformation to an immortalized cell type. Here we report the immortalization of an HDF cell line following transduction with cyclin A2 or cdk1 human genes via retroviral vectors. Fluorescence in situ hybridization (FISH) studies using the retroviral vector as a probe indicate that these cell lines are monoclonal. No telomerase activity could be detected in these cell lines, and the telomere length in the immortalized cells was observed to be 10-20 kb longer than that in low-passage cells from the parental fibroblast line. Cytogenetic studies revealed that the immortal lines share common chromosomal aberrations. FISH studies with a probe for p53 revealed loss of one copy of this gene which was associated with reduced steady-state levels of both p53 and p53-regulated p21(WAF1/Sdi1/CIP1) messages in both quiescent and proliferating immortalized cultures relative to the parental cells. Additional FISH studies with probes for p16(INK4a) and Rb, carried out after the immortalized cells proliferated in excess of 100 population doublings, also revealed loss of one copy of these genes in both cell lines. These cell lines, together with the well-characterized parental cells, could provide useful research material for the study of the mechanisms of immortalization and of regulation of proliferative senescence in HDF. FAU - Luo, Ping AU - Luo P AD - Department of Pathology, University of Washington Seattle, Seattle, WA 98195, USA. FAU - Tresini, Maria AU - Tresini M FAU - Cristofalo, Vincent AU - Cristofalo V FAU - Chen, Xiaoqin AU - Chen X FAU - Saulewicz, Anthony AU - Saulewicz A FAU - Gray, Matthew D AU - Gray MD FAU - Banker, Deborah E AU - Banker DE FAU - Klingelhutz, Aloysius L AU - Klingelhutz AL FAU - Ohtsubo, Motoaki AU - Ohtsubo M FAU - Takihara, Yoshihiro AU - Takihara Y FAU - Norwood, Thomas H AU - Norwood TH LA - eng GR - 1P30 AG13280/AG/NIA NIH HHS/United States GR - P01 AG01751/AG/NIA NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Exp Cell Res JT - Experimental cell research JID - 0373226 RN - 0 (CCNA2 protein, human) RN - 0 (CDKN1A protein, human) RN - 0 (Cyclin A) RN - 0 (Cyclin A2) RN - 0 (Cyclin-Dependent Kinase Inhibitor p16) RN - 0 (Cyclin-Dependent Kinase Inhibitor p21) RN - 0 (Cyclins) RN - 0 (Retinoblastoma Protein) RN - 0 (Tumor Suppressor Protein p53) RN - EC 2.7.11.22 (CDC2 Protein Kinase) RN - EC 2.7.7.49 (Telomerase) SB - IM MH - CDC2 Protein Kinase/biosynthesis/*genetics MH - Cell Division/genetics MH - Cell Line, Transformed MH - Cellular Senescence/*genetics MH - Chromosome Aberrations MH - Clone Cells/metabolism MH - Cyclin A/biosynthesis/*genetics MH - Cyclin A2 MH - Cyclin-Dependent Kinase Inhibitor p16/genetics MH - Cyclin-Dependent Kinase Inhibitor p21 MH - Cyclins/genetics MH - Fibroblasts/enzymology/*metabolism MH - Genetic Vectors/genetics MH - Humans MH - Infant, Newborn MH - Loss of Heterozygosity/genetics MH - Male MH - Retinoblastoma Protein/genetics MH - Retroviridae/genetics MH - Telomerase/metabolism MH - Transduction, Genetic/*methods MH - Tumor Suppressor Protein p53/genetics EDAT- 2004/03/17 05:00 MHDA- 2004/05/07 05:00 CRDT- 2004/03/17 05:00 PHST- 2003/07/09 00:00 [received] PHST- 2003/11/17 00:00 [revised] PHST- 2004/03/17 05:00 [pubmed] PHST- 2004/05/07 05:00 [medline] PHST- 2004/03/17 05:00 [entrez] AID - S0014482703006372 [pii] AID - 10.1016/j.yexcr.2003.11.030 [doi] PST - ppublish SO - Exp Cell Res. 2004 Apr 1;294(2):406-19. doi: 10.1016/j.yexcr.2003.11.030.